Ivan S. Alferiev The Children's Hospital of Philadelphia Biography Publications Institution JoVE Articles Ivan S. Alferiev has not added a biography. If you are Ivan S. Alferiev and would like to personalize this page please email our Author Liaison for assistance. Publications Experimental Single-Platform Approach to Enhance the Functionalization of Magnetically Targetable Cells ACS Applied Bio Materials. Jun, 2020 | Pubmed ID: 33251488 Optimizing Endothelial Cell Functionalization for Cell Therapy of Vascular Proliferative Disease Using a Direct Contact Co-culture System Drug Delivery and Translational Research. 08, 2018 | Pubmed ID: 28755158 Paraffin Processing of Stented Arteries Using a Postfixation Dissolution of Metallic and Polymeric Stents Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology. Nov - Dec, 2016 | Pubmed ID: 27616613 Enhanced Biocompatibility of CD47-functionalized Vascular Stents Biomaterials. May, 2016 | Pubmed ID: 26914699 Magnetically Enhanced Cell Delivery for Accelerating Recovery of the Endothelium in Injured Arteries Journal of Controlled Release : Official Journal of the Controlled Release Society. Jan, 2016 | Pubmed ID: 26704936 Nanoparticle-mediated Delivery of a Rapidly Activatable Prodrug of SN-38 for Neuroblastoma Therapy Biomaterials. May, 2015 | Pubmed ID: 25770994 Nanoparticle Delivery of an SN38 Conjugate is More Effective Than Irinotecan in a Mouse Model of Neuroblastoma Cancer Letters. May, 2015 | Pubmed ID: 25684664 The Effects of the Covalent Attachment of 3-(4-hydroxy-3,5-di-tert-butylphenyl) Propyl Amine to Glutaraldehyde Pretreated Bovine Pericardium on Structural Degeneration, Oxidative Modification, and Calcification of Rat Subdermal Implants Journal of Biomedical Materials Research. Part A. Jul, 2015 | Pubmed ID: 25546235 Targeting to Endothelial Cells Augments the Protective Effect of Novel Dual Bioactive Antioxidant/anti-inflammatory Nanoparticles Molecular Pharmaceutics. Jul, 2014 | Pubmed ID: 24877560 Real-time Analysis of Composite Magnetic Nanoparticle Disassembly in Vascular Cells and Biomimetic Media Proceedings of the National Academy of Sciences of the United States of America. Mar, 2014 | Pubmed ID: 24591603 Endothelial Targeting of Nanocarriers Loaded with Antioxidant Enzymes for Protection Against Vascular Oxidative Stress and Inflammation Biomaterials. Apr, 2014 | Pubmed ID: 24480537 The Susceptibility of Bioprosthetic Heart Valve Leaflets to Oxidation Biomaterials. Feb, 2014 | Pubmed ID: 24360721 Endovascular Gene Delivery from a Stent Platform: Gene- Eluting Stents Angiology: Open Access. 2013 | Pubmed ID: 26225356 Modulation of NO and ROS Production by AdiNOS Transduced Vascular Cells Through Supplementation with L-Arg and BH4: Implications for Gene Therapy of Restenosis Atherosclerosis. Sep, 2013 | Pubmed ID: 23958248 Intracellular Signaling Mechanisms Associated with CD47 Modified Surfaces Biomaterials. Nov, 2013 | Pubmed ID: 23948164 Adenoviral Vector Tethering to Metal Surfaces Via Hydrolyzable Cross-linkers for the Modulation of Vector Release and Transduction Biomaterials. Sep, 2013 | Pubmed ID: 23777912 Site-specific Gene Delivery to Stented Arteries Using Magnetically Guided Zinc Oleate-based Nanoparticles Loaded with Adenoviral Vectors FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. Jun, 2013 | Pubmed ID: 23407712 Magnetically Targeted Delivery of Therapeutic Agents to Injured Blood Vessels for Prevention of In-stent Restenosis Methodist DeBakey Cardiovascular Journal. Jan, 2012 | Pubmed ID: 22891107 Diminished Adhesion and Activation of Platelets and Neutrophils with CD47 Functionalized Blood Contacting Surfaces Biomaterials. Aug, 2012 | Pubmed ID: 22613135 Formulation and in Vitro Characterization of Composite Biodegradable Magnetic Nanoparticles for Magnetically Guided Cell Delivery Pharmaceutical Research. May, 2012 | Pubmed ID: 22274555 Triglycidyl Amine Crosslinking Combined with Ethanol Inhibits Bioprosthetic Heart Valve Calcification The Annals of Thoracic Surgery. Sep, 2011 | Pubmed ID: 21871270 The Effect of CD47 Modified Polymer Surfaces on Inflammatory Cell Attachment and Activation Biomaterials. Jul, 2011 | Pubmed ID: 21429575 CD47-dependent Molecular Mechanisms of Blood Outgrowth Endothelial Cell Attachment on Cholesterol-modified Polyurethane Biomaterials. Sep, 2010 | Pubmed ID: 20538335 Targeting Stents with Local Delivery of Paclitaxel-loaded Magnetic Nanoparticles Using Uniform Fields Proceedings of the National Academy of Sciences of the United States of America. May, 2010 | Pubmed ID: 20404175 Magnetically Driven Plasmid DNA Delivery with Biodegradable Polymeric Nanoparticles FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. Aug, 2007 | Pubmed ID: 17403937 Adenoviral Gene Vector Tethering to Nanoparticle Surfaces Results in Receptor-independent Cell Entry and Increased Transgene Expression Molecular Therapy : the Journal of the American Society of Gene Therapy. Sep, 2006 | Pubmed ID: 16807119 Bisphosphonate-mediated Gene Vector Delivery from the Metal Surfaces of Stents Proceedings of the National Academy of Sciences of the United States of America. Jan, 2006 | Pubmed ID: 16371477 Activated Polyurethane Modified with Latent Thiol Groups Biomaterials. Dec, 2002 | Pubmed ID: 12361613 Mitigação do apego de células transmitidas sanguíneas a implantes metálicos através da imobilização de peptídeos derivados do CD47 Vaishali V. Inamdar1, Emmett G. Fitzpatrick1, Ivan S. Alferiev1,2, Robert J. Levy1,2, Stanley J. Stachelek*1,2, Ilia Fishbein*1,2 1The Children's Hospital of Philadelphia, 2Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania JoVE 61545 Bioengineering
Mitigação do apego de células transmitidas sanguíneas a implantes metálicos através da imobilização de peptídeos derivados do CD47 Vaishali V. Inamdar1, Emmett G. Fitzpatrick1, Ivan S. Alferiev1,2, Robert J. Levy1,2, Stanley J. Stachelek*1,2, Ilia Fishbein*1,2 1The Children's Hospital of Philadelphia, 2Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania JoVE 61545 Bioengineering